Managed Care and the Pharmaceutical Industry - Top Issues, Health Care Reform and the Inter-linkages Bringing them Together

The managed care and the pharmaceutical industries have many conflicting goals. Managed care organizations are looking to reduce or – at the least – maintain drug costs, while pharmaceutical companies seek to increase the sale of their brand-name drugs. Common ground between the two industries can be difficult to find.

Shared goals do exist, though. Both the managed care industry and the pharmaceutical industry have a stake in how prescription drugs impact the cost and quality of health care. Both industries would like to see treatment persistence increase and, to this end, are continually investing in the research and development of disease management and medication compliance programs. Finally, both the managed care and the pharmaceutical drug industry are heavily influenced by the each other as well as other health care stakeholders, such as the Federal and state governments, health care providers and practitioners, and consumers.

This consultancy-style report provides an overview of the top issues in the managed care market and examines how the pharmaceutical industry, and other health care stakeholders, affect and are affected by the growth of managed care in the US market.

Scope

- Key issues in managed care

- Healthcare reform and the impact on managed care

- Managed care related to pharmaceutical industry, government and providers

- Short and long term outlook

Table Of Contents

Executive Summary

Top Issues in Managed Care

Government

Health IT

Cost and Quality

Collaboration

What Does this Mean for Pharmaceutical Executives

Managed Care and Health Care Reform

Types of Health Care Coverage

Types of Managed Care

Impact of the Health Care Reform Bill on Managed Care

Expanded Coverage to the Uninsured

What the Reform Bill Means for Managed Care

and the Pharmaceutical Industry

Inter-linkages in the US Health Care Industry

Managed Care

Pharmaceutical Industry

Government

Providers

Consumers

Summary The Short and Long Term Outlook

Key Reasons to Purchase

- Gain access to a fully sourced, executive assessment of the current state of the managed care industry

- Benefit from CBR’s evaluation of the inter-linkages between the key components of the US health care environment

- Understand the key issues facing managed care and where the pharmaceutical industry could support its relationship with its main health care partners moving forward

- Assess what the future of managed care holds for the pharmaceutical industry and where opportunities may exist to support your company’s growth moving forward